Human of Hungary reported gross profits of 206 million forint ($1.1million), a rise of 3%, in the first quarter of 1997. Turnover was just over 4 billion forint, up 19.8%. The company said that exports were 602 million forint in the quarter, more than doubling from the 1996 first-quarter level, reports MTI Econews. Human noted that its receivables have increased steadily to 2.64 billion forint as a result hospitals delaying payment.
The firm's subsidiary Humantrade made net sales of 2.9 billion forint, an increase of 543 million forint on the same period last year. Its product revenues derived from other companies were 1.8 billion forint, rising 32%. Its operating profits declined from 204 million forint to 173 million forint.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze